Aeovian Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $124M
Investors
- 12
About Aeovian Pharmaceuticals
Founded in 2012 by Stelios Tzannis (COO) and based in California, US, Aeovian Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for the treatment of rare and age-related diseases. In November 2025, Aeovian Pharmaceuticals, Inc.88 million post-money. Hulme. The company specializes in developing targeted, selective small molecules to restore cellular metabolic quality control. The firm’s primary goal is to address the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases. Aeovian’s development candidate, AV078, is the CNS penetrant selective mTORC1 inhibitor, which is in Phase 1 clinical trials for treating tuberous sclerosis complex (TSC) refractory epilepsy. In addition, the company has developed a proprietary library of potent and selective inhibitors of mTORC1 and CD38, targeting multiple rare and age-related diseases.
Who invested in Aeovian Pharmaceuticals
12 investors across 6 rounds
See all investors in Aeovian Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aeovian Pharmaceuticals
Who invested in Aeovian Pharmaceuticals?
Aeovian Pharmaceuticals has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aeovian Pharmaceuticals raised?
Aeovian Pharmaceuticals has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Aeovian Pharmaceuticals last raise money?
Aeovian Pharmaceuticals's most recent round on record is a Series B, in Nov 2025.
What does Aeovian Pharmaceuticals do?
Founded in 2012 by Stelios Tzannis (COO) and based in California, US, Aeovian Pharmaceuticals, Inc.
Where is Aeovian Pharmaceuticals headquartered?
Aeovian Pharmaceuticals is headquartered in Berkeley, US.
Which VCs invest in companies like Aeovian Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aeovian Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aeovian Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.